{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:48:50Z","timestamp":1791823730641,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570323"],"award-info":[{"award-number":["82570323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Science and Technology Development Program of Jiangsu Province-Clinical Frontier Technology","award":["BE2022754"],"award-info":[{"award-number":["BE2022754"]}]},{"name":"Clinical Medicine Expert Team (Class A) of Jinji Lake Health Talents Program of Suzhou Industrial Park","award":["SZYQTD202102"],"award-info":[{"award-number":["SZYQTD202102"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-026-02231-y","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:07:43Z","timestamp":1784246863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic effect of AIP and cystatin C: a study on cardiovascular risk prediction in populations with different glycemic statuses"],"prefix":"10.1186","volume":"18","author":[{"given":"Kuangyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"4","key":"2231_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41569-018-0119-4","volume":"16","author":"D Zhao","year":"2019","unstructured":"Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203\u201312.","journal-title":"Nat Rev Cardiol"},{"issue":"38","key":"2231_CR2","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1093\/eurheartj\/ehae466","volume":"45","author":"A Timmis","year":"2024","unstructured":"Timmis A, Aboyans V, Vardas P, Townsend N, Torbica A, Kavousi M, et al. European Society of Cardiology: the 2023 atlas of cardiovascular disease statistics. Eur Heart J. 2024;45(38):4019\u201362.","journal-title":"Eur Heart J"},{"issue":"25","key":"2231_CR3","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2231_CR4","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1161\/CIR.0000000000000652","volume":"139","author":"M McClellan","year":"2019","unstructured":"McClellan M, Brown N, Califf RM, Warner JJ. Call to action: urgent challenges in cardiovascular disease: a presidential advisory from the American Heart Association. Circulation. 2019;139(9):e44\u201354.","journal-title":"Circulation"},{"key":"2231_CR5","first-page":"25","volume":"6","author":"H Li","year":"2015","unstructured":"Li H, Ge J. Cardiovascular diseases in China: current status and future perspectives. Int J Cardiol Heart Vasc. 2015;6:25\u201331.","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"9833","key":"2231_CR6","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279\u201390.","journal-title":"Lancet"},{"issue":"19","key":"2231_CR7","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel WB, McGee DL. Diabetes and cardiovascular disease the framingham study. JAMA. 1979;241(19):2035\u20138.","journal-title":"JAMA"},{"issue":"7","key":"2231_CR8","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2337\/diacare.21.7.1167","volume":"21","author":"M Wei","year":"1998","unstructured":"Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care. 1998;21(7):1167\u201372.","journal-title":"Diabetes Care"},{"issue":"3","key":"2231_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2337\/dc07-9920","volume":"30","author":"DM Nathan","year":"2007","unstructured":"Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"2231_CR10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/ejhf.2403","volume":"24","author":"AM Jackson","year":"2022","unstructured":"Jackson AM, R\u00f8rth R, Liu J, Kristensen SL, Anand IS, Claggett BL, et al. Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2022;24(3):497\u2013509.","journal-title":"Eur J Heart Fail"},{"issue":"9438","key":"2231_CR11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet"},{"key":"2231_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev-publhealth-090419-102644","volume":"42","author":"JB Echouffo-Tcheugui","year":"2021","unstructured":"Echouffo-Tcheugui JB, Selvin E. Prediabetes and what it means: the epidemiological evidence. Annu Rev Public Health. 2021;42:59\u201377.","journal-title":"Annu Rev Public Health"},{"issue":"15","key":"2231_CR13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson AM, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407\u201318.","journal-title":"N Engl J Med"},{"issue":"7","key":"2231_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","volume":"379","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Sattar N, Eliasson B, Svensson AM, et al. Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2018;379(7):633\u201344.","journal-title":"N Engl J Med"},{"issue":"5","key":"2231_CR15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses. Arch Med Res. 2019;50(5):285\u201394.","journal-title":"Arch Med Res"},{"issue":"2","key":"2231_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/0003319720949804","volume":"72","author":"L Wang","year":"2021","unstructured":"Wang L, Chen F, Xiaoqi C, Yujun C, Zijie L. Atherogenic index of plasma is an independent risk factor for coronary artery disease and a higher SYNTAX score. Angiology. 2021;72(2):181\u20136.","journal-title":"Angiology"},{"issue":"7","key":"2231_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1sov\u00e1","year":"2001","unstructured":"Dobi\u00e1sov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583\u20138.","journal-title":"Clin Biochem"},{"issue":"5","key":"2231_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/157016111796642698","volume":"9","author":"DP Mikhailidis","year":"2011","unstructured":"Mikhailidis DP, Elisaf M, Rizzo M, Berneis K, Griffin B, Zambon A, et al. \u201cEuropean panel on low density lipoprotein (LDL) subclasses\u201d: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr Vasc Pharmacol. 2011;9(5):531\u20132.","journal-title":"Curr Vasc Pharmacol"},{"key":"2231_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6157605","author":"J Amrita","year":"2016","unstructured":"Amrita J, Mahajan M, Bhanwer AJ, Mohan G. Oxidative stress: an effective prognostic tool for an early detection of cardiovascular disease in menopausal women. Biochem Res Int. 2016. https:\/\/doi.org\/10.1155\/2016\/6157605.","journal-title":"Biochem Res Int"},{"issue":"1","key":"2231_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01505-w","volume":"20","author":"B Hamzeh","year":"2021","unstructured":"Hamzeh B, Pasdar Y, Mirzaei N, Faramani RS, Najafi F, Shakiba E, et al. Visceral adiposity index and atherogenic index of plasma as useful predictors of risk of cardiovascular diseases: evidence from a cohort study in Iran. Lipids Health Dis. 2021;20(1):82.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"2231_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02593-z","volume":"24","author":"Y Hu","year":"2025","unstructured":"Hu Y, Liang Y, Li J, Li X, Yu M, Cui W. Correlation between atherogenic index of plasma and cardiovascular disease risk across Cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):40.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2231_CR22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12933-024-02144-y","volume":"23","author":"Q Min","year":"2024","unstructured":"Min Q, Wu Z, Yao J, Wang S, Duan L, Liu S, et al. Association between atherogenic index of plasma control level and incident cardiovascular disease in middle-aged and elderly Chinese individuals with abnormal glucose metabolism. Cardiovasc Diabetol. 2024;23(1):54.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"2231_CR23","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/00033197211012129","volume":"72","author":"K Zhou","year":"2021","unstructured":"Zhou K, Qin Z, Tian J, Cui K, Yan Y, Lyu S. The atherogenic index of plasma: a powerful and reliable predictor for coronary artery disease in patients with type 2 diabetes. Angiology. 2021;72(10):934\u201341.","journal-title":"Angiology"},{"key":"2231_CR24","doi-asserted-by":"crossref","unstructured":"Huang X, Li C, Zeng P, Ling Y, Tan S, Bai Z, Shen S, Chen S, Nie B, Wang H et al. Non-traditional lipid-inflammatory parameters estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study. J Adv Res. 2025.","DOI":"10.1016\/j.jare.2025.11.029"},{"key":"2231_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.diabres.2018.02.003","volume":"139","author":"R Kaneko","year":"2018","unstructured":"Kaneko R, Sawada S, Tokita A, Honkura R, Tamura N, Kodama S, et al. Serum cystatin C level is associated with carotid arterial wall elasticity in subjects with type 2 diabetes mellitus: a potential marker of early-stage atherosclerosis. Diabetes Res Clin Pract. 2018;139:43\u201351.","journal-title":"Diabetes Res Clin Pract"},{"key":"2231_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2025.120721","volume":"580","author":"SA Dabravolski","year":"2025","unstructured":"Dabravolski SA, Elizova NV, Korchagina ER, Maltseva ON, Pavshintsev VV, Orekhov AN. Cystatin C in atherosclerotic cardiovascular disease. Clin Chim Acta. 2025;580:120721.","journal-title":"Clin Chim Acta"},{"issue":"11","key":"2231_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104345","volume":"28","author":"Y Wang","year":"2019","unstructured":"Wang Y, Zhang Y, Ma Q, Wang C, Xu Y, Sun H, et al. Determination of clinical cut-off values for serum cystatin C levels to predict ischemic stroke risk. J Stroke Cerebrovasc Dis. 2019;28(11):104345.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"Suppl E","key":"2231_CR28","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1093\/eurheartj\/suaa068","volume":"22","author":"L Gatto","year":"2020","unstructured":"Gatto L, Prati F. Subclinical atherosclerosis: how and when to treat it? Eur Heart J Suppl. 2020;22(Suppl E):E87-e90.","journal-title":"Eur Heart J Suppl"},{"issue":"6","key":"2231_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41569-024-01110-1","volume":"22","author":"K Grodecki","year":"2025","unstructured":"Grodecki K, Geers J, Kwiecinski J, Lin A, Slipczuk L, Slomka PJ, et al. Phenotyping atherosclerotic plaque and perivascular adipose tissue: signalling pathways and clinical biomarkers in atherosclerosis. Nat Rev Cardiol. 2025;22(6):443\u201355.","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"2231_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"issue":"2","key":"2231_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nri3793","volume":"15","author":"AR Tall","year":"2015","unstructured":"Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol. 2015;15(2):104\u201316.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2231_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/ni.2001","volume":"12","author":"GK Hansson","year":"2011","unstructured":"Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12(3):204\u201312.","journal-title":"Nat Immunol"},{"issue":"5","key":"2231_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1365-2796.2008.01965.x","volume":"263","author":"P Libby","year":"2008","unstructured":"Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med. 2008;263(5):517\u201327.","journal-title":"J Intern Med"},{"issue":"5","key":"2231_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2025.151567","volume":"44","author":"X-J Zhou","year":"2025","unstructured":"Zhou X-J, Zhang H. The genetics of IgA nephropathy: implications for future therapies. Semin Nephrol. 2025;44(5):151567.","journal-title":"Semin Nephrol"},{"issue":"5","key":"2231_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2025.151565","volume":"44","author":"J Novak","year":"2025","unstructured":"Novak J, Reily C, Steers NJ, Schumann T, Rizk DV, Julian BA, et al. Emerging biochemical and immunologic mechanisms in the pathogenesis of IgA nephropathy. Semin Nephrol. 2025;44(5):151565.","journal-title":"Semin Nephrol"},{"issue":"5","key":"2231_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2025.151566","volume":"44","author":"PJ Gleeson","year":"2025","unstructured":"Gleeson PJ, Monteiro RC. The role of mucosal immunity: what can we learn from animal and human studies? Semin Nephrol. 2025;44(5):151566.","journal-title":"Semin Nephrol"},{"issue":"1","key":"2231_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China health and retirement longitudinal study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2231_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12933-024-02314-y","volume":"23","author":"L Qu","year":"2024","unstructured":"Qu L, Fang S, Lan Z, Xu S, Jiang J, Pan Y, et al. Association between atherogenic index of plasma and new-onset stroke in individuals with different glucose metabolism status: insights from CHARLS. Cardiovasc Diabetol. 2024;23(1):215.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2231_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12933-025-02582-2","volume":"24","author":"R Assempoor","year":"2025","unstructured":"Assempoor R, Daneshvar MS, Taghvaei A, Abroy AS, Azimi A, Nelson JR, et al. Atherogenic index of plasma and coronary artery disease: a systematic review and meta-analysis of observational studies. Cardiovasc Diabetol. 2025;24(1):35.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2231_CR40","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12933-025-02960-w","volume":"24","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li S, Liu D, Gui J, Hu J, Wang Q, et al. The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2025;24(1):410.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2231_CR41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12933-025-02990-4","volume":"24","author":"N Zhang","year":"2025","unstructured":"Zhang N, Xie G, Jian G, Jiang K, Lu Z, Wang Z, et al. Association of cumulative changes in atherogenic index of plasma and its obesity-related derivatives with cardiovascular disease: emphasis on incremental risk of diabetes status. Cardiovasc Diabetol. 2025;24(1):435.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2231_CR42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12933-024-02449-y","volume":"23","author":"Y Zou","year":"2024","unstructured":"Zou Y, Lu S, Li D, Huang X, Wang C, Xie G, et al. Exposure of cumulative atherogenic index of plasma and the development of prediabetes in middle-aged and elderly individuals: evidence from the CHARLS cohort study. Cardiovasc Diabetol. 2024;23(1):355.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2231_CR43","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-025-02686-9","volume":"24","author":"G Huo","year":"2025","unstructured":"Huo G, Tang Y, Liu Z, Cao J, Yao Z, Zhou D. Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China Health and Retirement Longitudinal Study (CHARLS). Cardiovasc Diabetol. 2025;24(1):142.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2231_CR44","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/EDE.0b013e31821db37e","volume":"22","author":"TJ VanderWeele","year":"2011","unstructured":"VanderWeele TJ. Causal mediation analysis with survival data. Epidemiology. 2011;22(4):582\u20135.","journal-title":"Epidemiology"},{"issue":"1","key":"2231_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12933-025-02667-y","volume":"24","author":"H Lai","year":"2025","unstructured":"Lai H, Tu Y, Liao C, Zhang S, He L, Li J. Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011\u20132018. Cardiovasc Diabetol. 2025;24(1):109.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2231_CR46","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele TJ, Ding P. Sensitivity analysis in observational research: introducing the E-value. Ann Intern Med. 2017;167(4):268\u201374.","journal-title":"Ann Intern Med"},{"key":"2231_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.11.029","author":"X Huang","year":"2025","unstructured":"Huang X, Li C, Zeng P, Ling Y, Tan S, Bai Z, et al. Non-traditional lipid-inflammatory parameters estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study. J Adv Res. 2025. https:\/\/doi.org\/10.1016\/j.jare.2025.11.029.","journal-title":"J Adv Res"},{"key":"2231_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-03064-1","author":"C Li","year":"2026","unstructured":"Li C, Luo X, Chen Y, Lin J, Gu S. Predictive value of an integrated insulin resistance and lipometabolic score for cardiometabolic multimorbidity in older adults: a UK cohort study. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-025-03064-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2231_CR49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12933-024-02198-y","volume":"23","author":"M Rabiee Rad","year":"2024","unstructured":"Rabiee Rad M, Ghasempour Dabaghi G, Darouei B, Amani-Beni R. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: a systematic review and meta-analysis. Cardiovasc Diabetol. 2024;23(1):119.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2231_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02044-7","volume":"22","author":"H Zheng","year":"2023","unstructured":"Zheng H, Wu K, Wu W, Chen G, Chen Z, Cai Z, et al. Relationship between the cumulative exposure to atherogenic index of plasma and ischemic stroke: a retrospective cohort study. Cardiovasc Diabetol. 2023;22(1):313.","journal-title":"Cardiovasc Diabetol"},{"key":"2231_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58020299","author":"J Vekic","year":"2022","unstructured":"Vekic J, Zeljkovic A, Cicero AFG, Janez A, Stoian AP, Sonmez A, et al. Atherosclerosis development and progression: the role of atherogenic small, dense LDL. Medicina (Kaunas). 2022. https:\/\/doi.org\/10.3390\/medicina58020299.","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"2231_CR52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12944-017-0545-z","volume":"16","author":"J Liu","year":"2017","unstructured":"Liu J, Yang R, Zhou M, Mao W, Li H, Zhao H, et al. Fractional esterification rate of cholesterol in high-density lipoprotein associates with risk of coronary heart disease. Lipids Health Dis. 2017;16(1):162.","journal-title":"Lipids Health Dis"},{"issue":"3","key":"2231_CR53","first-page":"152","volume":"46","author":"M Dobi\u00e1sov\u00e1","year":"2000","unstructured":"Dobi\u00e1sov\u00e1 M, Frohlich J. The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy. Vnitr Lek. 2000;46(3):152\u20136.","journal-title":"Vnitr Lek"},{"issue":"4","key":"2231_CR54","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1515\/cclm-2013-0525","volume":"52","author":"J Dong","year":"2014","unstructured":"Dong J, Yu S, Yang R, Li H, Guo H, Zhao H, et al. A simple and precise method for direct measurement of fractional esterification rate of high density lipoprotein cholesterol by high performance liquid chromatography. Clin Chem Lab Med. 2014;52(4):557\u201364.","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"2231_CR55","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1161\/01.ATV.17.11.2713","volume":"17","author":"RS Gray","year":"1997","unstructured":"Gray RS, Robbins DC, Wang W, Yeh JL, Fabsitz RR, Cowan LD, et al. Relation of LDL size to the insulin resistance syndrome and coronary heart disease in American Indians. The Strong Heart Study. Arterioscler Thromb Vasc Biol. 1997;17(11):2713\u201320.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2231_CR56","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.numecd.2005.06.010","volume":"15","author":"S Frontoni","year":"2005","unstructured":"Frontoni S, Bracaglia D, Gigli F. Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes. Nutr Metab Cardiovasc Dis. 2005;15(6):441\u20139.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"2231_CR57","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1463-1326.2004.00446.x","volume":"7","author":"DE Rosenberg","year":"2005","unstructured":"Rosenberg DE, Jabbour SA, Goldstein BJ. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment. Diabetes Obes Metab. 2005;7(6):642\u201353.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"2231_CR58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1053\/j.ajkd.2011.11.042","volume":"59","author":"BC Astor","year":"2012","unstructured":"Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, et al. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012;59(5):653\u201362.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"2231_CR59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1568026611313020006","volume":"13","author":"C Angelidis","year":"2013","unstructured":"Angelidis C, Deftereos S, Giannopoulos G, Anatoliotakis N, Bouras G, Hatzis G, et al. Cystatin C: an emerging biomarker in cardiovascular disease. Curr Top Med Chem. 2013;13(2):164\u201379.","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"2231_CR60","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1161\/CIRCOUTCOMES.110.957696","volume":"3","author":"M Lee","year":"2010","unstructured":"Lee M, Saver JL, Huang WH, Chow J, Chang KH, Ovbiagele B. Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis. Circ Cardiovasc Qual Outcomes. 2010;3(6):675\u201383.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"11","key":"2231_CR61","first-page":"20540","volume":"8","author":"M Bi","year":"2015","unstructured":"Bi M, Huang Z, Li P, Cheng C, Huang Y, Chen W. The association between elevated cystatin C levels with myocardial infarction: a meta-analysis. Int J Clin Exp Med. 2015;8(11):20540\u20137.","journal-title":"Int J Clin Exp Med"},{"issue":"5","key":"2231_CR62","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/joim.12169","volume":"275","author":"P Svensson-F\u00e4rbom","year":"2014","unstructured":"Svensson-F\u00e4rbom P, Ohlson Andersson M, Almgren P, Hedblad B, Engstr\u00f6m G, Persson M, et al. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease. J Intern Med. 2014;275(5):506\u201321.","journal-title":"J Intern Med"},{"issue":"8","key":"2231_CR63","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.numecd.2022.05.016","volume":"32","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yang S, Chen J, Zhang Z, He P, Zhou C, et al. Associations of serum cystatin C and its change with new-onset cardiovascular disease in Chinese general population. Nutr Metab Cardiovasc Dis. 2022;32(8):1963\u201371.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"8","key":"2231_CR64","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/01.ATV.0000134530.27208.41","volume":"24","author":"J Liu","year":"2004","unstructured":"Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(8):1359\u201366.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2231_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-117","volume":"11","author":"J Frosteg\u00e5rd","year":"2013","unstructured":"Frosteg\u00e5rd J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11:117.","journal-title":"BMC Med"},{"issue":"4","key":"2231_CR66","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2174\/1567202614666171116102504","volume":"14","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Sun L. Cystatin C in cerebrovascular disorders. Curr Neurovasc Res. 2017;14(4):406\u201314.","journal-title":"Curr Neurovasc Res"},{"issue":"9","key":"2231_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270289","volume":"17","author":"KA Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez KA, Stickel AM, Kaur SS, Ramos AR, Gonz\u00e1lez HM, Tarraf W. Serum cystatin-C is linked to increased prevalence of diabetes and higher risk of mortality in diverse middle-aged and older adults. PLoS ONE. 2022;17(9):e0270289.","journal-title":"PLoS ONE"},{"issue":"6","key":"2231_CR68","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00125-011-2096-6","volume":"54","author":"K Sahakyan","year":"2011","unstructured":"Sahakyan K, Lee KE, Shankar A, Klein R. Serum cystatin C and the incidence of type 2 diabetes mellitus. Diabetologia. 2011;54(6):1335\u201340.","journal-title":"Diabetologia"},{"issue":"1","key":"2231_CR69","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1073\/pnas.76.1.333","volume":"76","author":"JL Goldstein","year":"1979","unstructured":"Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76(1):333\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6801","key":"2231_CR70","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233\u201341.","journal-title":"Nature"},{"issue":"4","key":"2231_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJM198207223070401","volume":"307","author":"MR Bristow","year":"1982","unstructured":"Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307(4):205\u201311.","journal-title":"N Engl J Med"},{"issue":"10486","key":"2231_CR72","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(25)00055-8","volume":"405","author":"S Zaman","year":"2025","unstructured":"Zaman S, Wasfy JH, Kapil V, Ziaeian B, Parsonage WA, Sriswasdi S, et al. The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma. Lancet (London, England). 2025;405(10486):1264\u2013312.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"2231_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2026.102830","volume":"37","author":"RR Gaddam","year":"2026","unstructured":"Gaddam RR, Pathuri M, Deb P, Dwivedi S, Vikram A, Kasina V, et al. Engineered miR-122 inhibitors preserve endothelial mitochondrial function and prevent vascular dysfunction in obesity-associated prediabetes. Mol Ther Nucleic Acids. 2026;37(1):102830.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2231_CR74","doi-asserted-by":"publisher","first-page":"101349","DOI":"10.1016\/j.ajpc.2025.101349","volume":"24","author":"C Sardu","year":"2025","unstructured":"Sardu C, Nicoletti GF, Trotta MC, Pieretti G, Gatta G, Grella R, et al. Endothelial dysfunction and cardiovascular outcomes in pre-menopausal women with high vs low breast fat accumulation the role of TSP-1. Am J Prev Cardiol. 2025;24:101349.","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"2231_CR75","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12933-025-02698-5","volume":"24","author":"J Liu","year":"2025","unstructured":"Liu J, Chen K, Tang M, Mu Q, Zhang S, Li J, et al. Oxidative stress and inflammation mediate the adverse effects of cadmium exposure on all-cause and cause-specific mortality in patients with diabetes and prediabetes. Cardiovasc Diabetol. 2025;24(1):145.","journal-title":"Cardiovasc Diabetol"},{"issue":"38","key":"2231_CR76","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/eurheartj\/ehaf314","volume":"46","author":"S Romeo","year":"2025","unstructured":"Romeo S, Vidal-Puig A, Husain M, Ahima R, Arca M, Bhatt DL, et al. Clinical staging to guide management of metabolic disorders and their sequelae: a European atherosclerosis society consensus statement. Eur Heart J. 2025;46(38):3685\u2013713.","journal-title":"Eur Heart J"},{"issue":"5","key":"2231_CR77","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.2337\/dc05-2179","volume":"29","author":"MA Abdul-Ghani","year":"2006","unstructured":"Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29(5):1130\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"2231_CR78","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/jama.294.3.334","volume":"294","author":"E Ingelsson","year":"2005","unstructured":"Ingelsson E, Sundstr\u00f6m J, Arnl\u00f6v J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA. 2005;294(3):334\u201341.","journal-title":"JAMA"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-026-02231-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02231-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-026-02231-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:04:31Z","timestamp":1791821071000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13098-026-02231-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2231"],"URL":"https:\/\/doi.org\/10.1186\/s13098-026-02231-y","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The CHARLS study was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki. The research protocol received approval from the Institutional Review Board of Peking University. Prior to their participation, written informed consent was obtained from all individuals involved in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"215"}}